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Results: Five localized amyloidosis are identiﬁed. Among them, two of
them are originated from urinary bladder and three from renal pelvis and
ureter. None of our cases showed evidence of systemic amyloidosis.
Painless gross hematuria is the most frequent symptom of localized
amyloidosis of the urinary tract. Patients with bladder involvement were
treated with localized bladder resection; thosewith renal pelvis and ureter
involvement, two underwent ureteroscopic resection and one received
percutaneous nephroscopic resection. After surgical resection, no com-
plications were noted in patients with bladder involvement. Of patients
with ureter and renal pelvis involvement, one require long-term double-J
exchange for persisted obstructive uropathy, two developed permanent
decrease of renal function.
Conclusion: Localized amyloidosis of the urinary tract is a rare condition
that mimickingmalignancy of the urinary tracts. To pathologic diagnosis of
amyloidosis of the urinary tract, Congo red stain is essential. The treatment
is usually conservative with observation or surgical resection with long-
term follow up. Amyloidosis of renal pelvis and ureter cause more severe
consequences than those with bladder involvement.
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Purpose: Arteriovenous ﬁstulas of the kidney are rare and are classiﬁed as
acquired, idiopathic or arising in a congenital arteriovenous malformation
which may leading to hypertension and acute heart failure. The treatment
of Renal Arteriovenous ﬁstula aims at preserving the most of the renal
parenchyma and, concomitantly, eradicating the symptoms and hemo-
dynamic effects caused by the Renal Arteriovenous ﬁstula.
We would like to introduce the cases of Renal Arteriovenous ﬁstula in our
hospital.
Materials and Methods: We search our cases by identifying the ﬁnal
diagnosis as Renal Arteriovenous ﬁstula within recent 10 year period
(2005~2015).
Case report: Totally four cases were found as follows
Conclusion: Arteriovenous ﬁstulas of the kidney are rare and are classiﬁed
as acquired, idiopathic or arising in a congenital arteriovenous malfor-
mation. All of our four cases are idiopathic with three of them are symp-
tomatic. All of them treated successfully by TAE with symptoms relieved
and hemodynamics were stable. No obvious damage of renal functionwere
noticed. We would like to share our cases and compare with literatures
published to give a whole picture of the disease in diagnosis, treatment
and Prognosis.
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BENZYL ISOTHIOCYANATE UP-REGULATES MIR-99A-5P AND INDUCES
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Purpose: The development of novel methods for BC therapy, particularly
for recurring BC, is warranted. Benzyl isothocyanate (BITC) is a natural
compound that produced by Brassicaceae species, and displays anticarci-
nogenic activities. Besides apoptosis induction, BITC also inducesautophagy through inhibiting mTOR. Human miR-99a-5p was reported to
be down-regulated in BC and it potentially targets to mTOR. We therefore
hypothesized that BITC may induce autophagy through regulating miR-
99a-5p to suppress mTOR expression and its downstream signaling.
Materials and Methods: Human BC cell lines (5637 and T24) were used in
this study. To facilitate the overexpression of miR-99a-5p, the matured
miR-99a-5p was inserted to a small RNA expression vector (pSM) to
generate pSM-99a. Detection of miR-99a-5p expression level in pSM-99a
transfected or BITC-treated cells was performed by miRNA qPCR. We uti-
lized a luciferase reporter vector bearing anti-sense miR-99a-5psequences
to conﬁrm the up-regulation of miR-99a-5p, and to act as an inhibitor to
the miR-99a-5p in BITC-treated BC cells. Protein expression level of LC3-II,
mTOR, IGF1R, FGFR3 was monitored in pSM-99a transfected or BITC-
treated cells using Western blot.
Results: We ﬁrst veriﬁed that BITC decreased cell viability by induction of
apoptosis in human BC cells, as it does in prostate cancer cells. BITC also
induced autophagy through decreased the mTOR expression level. Over-
expression ofmiR-99a-5p, which is down-regulated in bladder cancer cells,
resulted in decreased cell viability and inhibition ofmTOR protein level.We
found the expression level ofmTOR, IGF1R and FGFR3 that are direct targets
of miR-99a-5p was decreased in BITC-treated as well as the pSM-99a
transfected BC cells. These results lead us to detect the expression level of
miR-99a-5p in BITC-treated cells. The expression level of miR-99a-5p in
BITC-treated BC cells was detected by two methods: (a) miRNA qPCR and
(b) luciferase reporter assays. The results showed that miR-99a-5p was up-
regulated by BITC treatment. BITC induces autophagy by inhibiting mTOR
expression; and forced expression of miR-99a-5p was able to mimic the
autophagy induction and mTOR inhibition asin BITC-treated cells. The
transfection of luciferase reporter that competes and inhibits BITC-induced
miR-99a-5p resulted in the restoration of mTOR expression and decreased
level of autophagy, suggesting autophagy induction in BITC-treated cells is
partially, if not all, through the up-regulation of miR-99a-5p.
Conclusion: Our results indicated that miR-99a-5p plays an important role
in BITC-induced autophagy in BC cells.
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Purpose: The oncogenic tyrosine kinase RON (recepteur d'origine Nantais)
is involved in human bladder urothelial carcinogenesis and can cross-talk
with epidermal growth factor receptor (EGFR) during nuclear trans-
location as a transcriptional factor. Despite this, little is known whether
RON expression can impact the survival in patients with upper tract uro-
thelial carcinoma (UTUC). The aim of the study is to investigate the fre-
quency and clinicopathologic correlates of RON receptor expression in
UTUC patients.
Materials and Methods: Immunohistochemical staining for RON, EGFR,
and HER2 were done with serial sections from archival specimens of 125
patients who underwent nephroureterectomy plus bladder cuff resection
(median follow-up 50months, range 1 to 177). The correlates between RON
receptor expression and overall survival were analyzed by KaplaneMeier
plots, with the log-rank test and Cox proportional hazards model.
Results: RON, EGFR, and HER2 expression was present in 45 of 125 (36.0%),
17 of 125 (13.6%), and 13 of 94 (13.8%) tumors, respectively. Among 45 RON
(+) tumors, 8 (17.7 %) and 5 (11.1 %) had EGFR and HER2 co-expression,
respectively. Overall, RON expression can predict with poorer disease-
speciﬁc overall survival (p¼ 0.0051, HR, 2.36, 95 CI%, 1.33-4.92). Neither co-
expressed with HER2 (p ¼ 0.285, HR, 1.85, 95 CI%, 0.46-10.5) nor with EGFR
(p ¼ 0.900, HR, 1.06, 95 CI%, 0.36-3.13), the prognostic values did not reach
any statistical signiﬁcance due to small number of sub-group patients.
Conclusion: RON expression predicts for disease-speciﬁc overall survival
in UTUC patients.
